KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Encompass Health (EHC) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Encompass Health (EHC) over the last 17 years, with Q3 2025 value amounting to 0.85%.

  • Encompass Health's EBITDA Margin fell 100400.0% to 0.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 7.22%, marking a year-over-year decrease of 33500.0%. This contributed to the annual value of 11.1% for FY2024, which is 14600.0% up from last year.
  • Latest data reveals that Encompass Health reported EBITDA Margin of 0.85% as of Q3 2025, which was down 100400.0% from 3.11% recorded in Q2 2025.
  • In the past 5 years, Encompass Health's EBITDA Margin ranged from a high of 14.18% in Q2 2021 and a low of 0.85% during Q3 2025
  • For the 5-year period, Encompass Health's EBITDA Margin averaged around 9.77%, with its median value being 10.39% (2022).
  • Its EBITDA Margin has fluctuated over the past 5 years, first skyrocketed by 110600bps in 2021, then crashed by -100400bps in 2025.
  • Encompass Health's EBITDA Margin (Quarter) stood at 11.1% in 2021, then dropped by -7bps to 10.33% in 2022, then fell by -8bps to 9.55% in 2023, then grew by 22bps to 11.69% in 2024, then plummeted by -93bps to 0.85% in 2025.
  • Its EBITDA Margin was 0.85% in Q3 2025, compared to 3.11% in Q2 2025 and 13.5% in Q1 2025.